These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25719833)

  • 1. DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach.
    Hubers AJ; Heideman DA; Burgers SA; Herder GJ; Sterk PJ; Rhodius RJ; Smit HJ; Krouwels F; Welling A; Witte BI; Duin S; Koning R; Comans EF; Steenbergen RD; Postmus PE; Meijer GA; Snijders PJ; Smit EF; Thunnissen E
    Br J Cancer; 2015 Mar; 112(6):1105-13. PubMed ID: 25719833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined sputum hypermethylation and eNose analysis for lung cancer diagnosis.
    Hubers AJ; Brinkman P; Boksem RJ; Rhodius RJ; Witte BI; Zwinderman AH; Heideman DA; Duin S; Koning R; Steenbergen RD; Snijders PJ; Smit EF; Sterk PJ; Thunnissen E
    J Clin Pathol; 2014 Aug; 67(8):707-11. PubMed ID: 24915850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years.
    Hubers AJ; Heideman DA; Duin S; Witte BI; de Koning HJ; Groen HJ; Prinsen CF; Bolijn AS; Wouters M; van der Meer SE; Steenbergen RD; Snijders PJ; Uyterlinde A; Berkhof H; Smit EF; Thunnissen E
    J Clin Pathol; 2017 Mar; 70(3):250-254. PubMed ID: 27496969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation analysis in spontaneous sputum for lung cancer diagnosis.
    Hubers AJ; van der Drift MA; Prinsen CF; Witte BI; Wang Y; Shivapurkar N; Stastny V; Bolijn AS; Hol BE; Feng Z; Dekhuijzen PN; Gazdar AF; Thunnissen E
    Lung Cancer; 2014 May; 84(2):127-33. PubMed ID: 24598366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection.
    Su Y; Fang H; Jiang F
    Clin Epigenetics; 2016; 8():109. PubMed ID: 27777637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged sampling of spontaneous sputum improves sensitivity of hypermethylation analysis for lung cancer.
    Hubers AJ; Heideman DA; Herder GJ; Burgers SA; Sterk PJ; Kunst PW; Smit HJ; Postmus PE; Witte BI; Duin S; Snijders PJ; Smit EF; Thunnissen E
    J Clin Pathol; 2012 Jun; 65(6):541-5. PubMed ID: 22461647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation Between RASSF1A Gene Promoter Hypermethylation in Serum or Sputum and Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis.
    Zhang Z; Yan S; Cui H; Chen H; Liu J
    Med Sci Monit; 2019 Jul; 25():5518-5524. PubMed ID: 31342946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.
    Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F
    Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study.
    Cirincione R; Lintas C; Conte D; Mariani L; Roz L; Vignola AM; Pastorino U; Sozzi G
    Int J Cancer; 2006 Mar; 118(5):1248-53. PubMed ID: 16152615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epigenetic classifier for early stage lung cancer.
    Su Y; Fang HB; Jiang F
    Clin Epigenetics; 2018; 10():68. PubMed ID: 29796119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum.
    Hulbert A; Jusue-Torres I; Stark A; Chen C; Rodgers K; Lee B; Griffin C; Yang A; Huang P; Wrangle J; Belinsky SA; Wang TH; Yang SC; Baylin SB; Brock MV; Herman JG
    Clin Cancer Res; 2017 Apr; 23(8):1998-2005. PubMed ID: 27729459
    [No Abstract]   [Full Text] [Related]  

  • 12. Methylation of RAS association domain family protein 1A as a biomarker of lung cancer.
    Grote HJ; Schmiemann V; Geddert H; Bocking A; Kappes R; Gabbert HE; Sarbia M
    Cancer; 2006 Apr; 108(2):129-34. PubMed ID: 16444703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma.
    Kneip C; Schmidt B; Seegebarth A; Weickmann S; Fleischhacker M; Liebenberg V; Field JK; Dietrich D
    J Thorac Oncol; 2011 Oct; 6(10):1632-8. PubMed ID: 21694641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnostic markers for lung cancer in sputum and plasma.
    Wang YC; Hsu HS; Chen TP; Chen JT
    Ann N Y Acad Sci; 2006 Sep; 1075():179-84. PubMed ID: 17108209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Indirect Efficacy Comparison of DNA Methylation in Sputum for Early Screening and Auxiliary Detection of Lung Cancer: A Meta-Analysis.
    Liu D; Peng H; Sun Q; Zhao Z; Yu X; Ge S; Wang H; Fang H; Gao Q; Liu J; Wu L; Song M; Wang Y
    Int J Environ Res Public Health; 2017 Jun; 14(7):. PubMed ID: 28644424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation biomarkers offer improved diagnostic efficiency in lung cancer.
    Nikolaidis G; Raji OY; Markopoulou S; Gosney JR; Bryan J; Warburton C; Walshaw M; Sheard J; Field JK; Liloglou T
    Cancer Res; 2012 Nov; 72(22):5692-701. PubMed ID: 22962272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort.
    Belinsky SA; Liechty KC; Gentry FD; Wolf HJ; Rogers J; Vu K; Haney J; Kennedy TC; Hirsch FR; Miller Y; Franklin WA; Herman JG; Baylin SB; Bunn PA; Byers T
    Cancer Res; 2006 Mar; 66(6):3338-44. PubMed ID: 16540689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
    Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
    Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An epigenetic marker panel for detection of lung cancer using cell-free serum DNA.
    Begum S; Brait M; Dasgupta S; Ostrow KL; Zahurak M; Carvalho AL; Califano JA; Goodman SN; Westra WH; Hoque MO; Sidransky D
    Clin Cancer Res; 2011 Jul; 17(13):4494-503. PubMed ID: 21610147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of lung cancer associated with genes methylation in the peripheral blood.
    Tan S; Sun C; Wei X; Li Y; Wu Y; Yan Z; Feng F; Wang J; Wu Y
    Exp Lung Res; 2013; 39(4-5):182-90. PubMed ID: 23614702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.